NCT Number: NCT00062400
Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
RATIONALE: Adjuvant therapy given after surgery for early breast cancer may cause infertility. Assessing young women's attitudes and feelings about the risk of infertility may help improve the ability to plan effective treatment.
PURPOSE: This clinical trial is studying young women's attitudes and feelings about the risk of infertility related to adjuvant therapy for stage I or stage II breast cancer.
Looking for future studies?
Notify MeKey information
Conditions
Age range
0 year–35 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Centre Hospitalier Etterbeek Ixelles, Brussels, Belgium
About this study
OBJECTIVES:
- Determine the attitude toward the risk of infertility related to adjuvant therapy in women with early breast cancer.
- Correlate, if possible, the patient's attitude with the fact that the patient already has children or the time interval between the date of breast cancer diagnosis and the date of study participation.
OUTLINE: This is a multicenter study.
Patients complete a questionnaire administered by a nontreating physician.
PROJECTED ACCRUAL: A total of 385 patients will be accrued for this study.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Histologically or cytologically confirmed prior or current diagnosis of breast cancer
- Stage I or II
- No relapsed disease
- No evidence of infertility
- Regular menses or regular hormonal contraception use for the past 3 months
- Hormonal status:
- Not specified
PATIENT CHARACTERISTICS:
Age
- 35 and under at diagnosis
Sex
- Female
Menopausal status
- Premenopausal
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- No psychological, familial, sociological, or geographical condition that would preclude study compliance
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- Not specified
Endocrine therapy
- See Disease Characteristics
Radiotherapy
- Not specified
Surgery
- Not specified
Treatment and study plan
Primary outcomes
-
Patients who would agree to have chemotherapy if it reduces their chances of having children as assessed by questionnaire
Sponsors and collaborators
Lead sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Network
Collaborators
- ETOP IBCSG Partners Foundation
- German Adjuvant Breast Cancer Group
Registry information
Official study title
A Survey of the Breast International Group (B.I.G.) to Assess the Attitude of Patients Aged Less Than 35 Years, With Early Breast Cancer, Toward the Risk of Loss of Fertility Related to Adjuvant Therapies
Important dates
- Study start
- 2003
- Primary completion
- 2008
- Study completion
- 2008
- First posted
- Jun 6, 2003
- Registry last updated
- May 12, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
NCT00309933
Behavior, Breast Cancer
Monterey, California, United States
View Trial DetailsReproductive Health Survivorship Care Plan
NCT02667626
Breast Cancer, Breast Diseases
La Jolla, California, United States
View Trial DetailsPilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
NCT00343382
Behavior, Breast Cancer
Aurora, Colorado, United States
View Trial DetailsTamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
NCT00667121
Behavior, Behavioral Symptoms
Indianapolis, Indiana, United States
View Trial Details